International recommendations on diabetes

We are proud to announce the publication of the world’s first international recommendations on smoking cessation for people with type 2 diabetes. These guidelines have just appeared in the prestigious journal „Diabetes Research and Clinical Practice.”

We are particularly delighted that researchers from our Department of Human Epigenetics - Prof. Magdalena Walicka, MD and Prof. Edward Franek, MD - participated in the work of the international expert panel (the DiaSmokeFree Working Group) and Magdalena Walicka is the lead author of these groundbreaking recommendations!

Although smoking significantly increases the risk of chronic complications associated with type 2 diabetes - particularly cardiovascular issues—physicians have previously lacked comprehensive guidelines tailored to the specific nature of this disease. The new recommendations are the result of work by the DiaSmokeFree group - 35 experts from 13 countries established at the initiative of CoEHAR, an interdisciplinary research center based at the University of Catania in Italy.

The new consensus transforms standard smoking cessation advice into a structured, personalized clinical process. It provides physicians with a practical management framework covering the choice of pharmacotherapy, behavioral support, relapse prevention, metabolic monitoring, and consideration of interactions between medications and tobacco smoke.

As the lead author, Magdalena Walicka summarizes:

"People with type 2 diabetes who smoke face an exceptionally high burden of preventable complications. Yeti t is shockingto note that cessation suport has rarely been tailored to their clinical needs."

We extend our sincere congratulations to our researchers and the entire team on this tremendous international success, which will have a tangible impact on diabetes care standards worldwide!

More information: CLICK HERE.

Symposium invitation

 

  Dear Colleagues and Friends,

  The Organizers, consisting of:
    - Mossakowski Medical Research Institite, Polish Academy of Sciences
    - The Committee on Neurobiology of the Polish Academy of Sciences
    - Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences

    
is pleased to invite you to the 17th International Symposium "Molecular Basis of Pathology and Therapy in Neurological Disorders" which will take place on 15 - 16 October 2026 at the Conference Center of the Nalecz Institute of Biocybernetics and Biomedical Engineering in Warsaw, Ks. Trojdena 4 st.

The program includes 4 thematic sessions and 2 poster presentation sessions. Abstracts of the short oral presentations and posters will be published in Folia Neuropathologica journal.

Session topics :
- Advancing Human Neural Models: From Organoids to Physiologically Relevant Systems
- Glial cells in neurodevelopmental and neurodegenerative diseases
- Novel aspects of calcium signaling in the Central Nervous System
- Neurodegenerative and Neuromuscular Diseases: From Molecular Mechanisms to Pathophysiology

The following speakers have confirmed their participation in the conference:

• Laura Batlle Morera (Centre for Genomic Regulation, CRG, Barcelona, Spain)
• Ira Espuny-Camacho(University of Liège, Liège, Belgium)
• Leonora Buzanska (Department of Stem Cell Bioengineering, , Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland)
• Katarzyna Tokarska (The Centre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Warsaw, Poland)
• Michal K. Stachowiak (University at Buffalo, Buffalo, USA)
• Maurice Whelan (European Commission Joint Research Centre, JCR, Ispra, Italy)
• Julien Puyal (Department of Fundamental Neurosciences, University of Lausanne, Lausanne Switzerland)
• Anna Malik (Faculty of Biology, University of Warsaw, Warsaw, Poland)
• Sujith Sajja (The Geneva Foundation,Bethesda, Maryland, USA)
• Amit Srivastava (Thomas Jefferson University, Philadelphia, USA)
• Francesco Moccia (Department of Medicine and Health Sciences University of Molise, Campobasso,Italy)
• Urszula Wojda (Head of Laboratory of Preclinical Testing of Higher Standard
• Neurobiology Center, Nencki Institute of Experimental Biology, Warsaw, Poland)
• Karolina Pircs (HCEMM-SU Neurobiology and Neurodegenerative Diseases Research Group Institute of Clinical Pathophysiology Semmelweis University Budapest, Budapest, Hungary)
• Tito Calì (Department of Biomedical Sciences University of Padova, Padova, Italy)
• Martin Heine(Institute of Developmental and Neurobiology (iDN) Functional Neurobiology; Johannes Gutenberg-University, Mainz, Germany)
• Silvia V. Conde, (NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal)
• Pawel Grieb, (Farmacology Department Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland)
• Magdalena Czeredys (Department of Stem Cell Bioengineering, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland)
• Robert Ostrowski (Department of Neurooncology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland)
• Anna Wilkaniec (Department of Cellular Signaling, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland)

   
On behalf of the Organizers, we cordially invite you to actively participate in this event.

Online registration for the conference will remain open untilSeptember 30, 2026.

For more information, please visit: ncs2026.imdik.pan.pl  

   
   
   

Doctoral School - recruitment

We invite you to apply to the Translational Medicine Doctoral School!

Click on the image for full details.

Deadlines: July & August 2026

 

Lecture invitation: dr. Karolina Pircs

The Huntington Research Group at the Department of Stem Cell Bioengineering at the MMRI PAS is pleased to invite you to a lecture by

Dr. Karolina Pircs titled Direct Neural Reprogramming: A Cellular Model of Human Brain Aging and Rejuvenation. 

Dr. Karolina Pircs is a Group Leader at the HCEMM-SU Neurobiology and Neurodegenerative Diseases Research Group,
Institute of Clinical Pathophysiology, Semmelweis University, Budapest, Hungary.  

Date: 2 June 2026
Time: 12:00 PM - 1:30 PM
Venue: D204 IMDiK PAN, 2nd Floor (onsite and online)

We warmly encourage all researchers, students, and staff interested in neurobiology, aging, and neurodegeneration to attend.
If any of you would like to attend the lecture online, please contact us directly: This email address is being protected from spambots. You need JavaScript enabled to view it.